ASCO 2023 | Barriers to adopting medicinal cannabis for supportive care in cancer

Antony Mersiades, MD, FRACP, MBBS, University of Sydney & NHMRC Clinical Trials Centre & Northern Beaches Cancer Service, Sydney, Australia, describes challenges in using medicinal cannabis in the clinic. More detailed clinical trials such as the CannabisCINV study (ACTRN12616001036404) are needed to properly evaluate the efficacy of medicinal cannabis. The legality of medicinal cannabis is an additional hurdle, where it may still be illegal in certain jurisdictions. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.